- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of lipid nanoparticle size on mRNA vaccine immunogenicity
Authors
Keywords
Vaccine, Nanoparticle, mRNA, Size, Lipid
Journal
JOURNAL OF CONTROLLED RELEASE
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-05-19
DOI
10.1016/j.jconrel.2021.05.021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA
- (2020) Siddharth Patel et al. Nature Communications
- Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
- (2020) Amy S. Espeseth et al. npj Vaccines
- The proximal origin of SARS-CoV-2
- (2020) Kristian G. Andersen et al. NATURE MEDICINE
- SARS-CoV-2 (COVID-19) by the numbers
- (2020) Yinon M Bar-On et al. eLife
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of mRNA chemistry and manufacturing process on innate immune activation
- (2020) Jennifer Nelson et al. Science Advances
- Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
- (2019) Susannah L. Hewitt et al. Science Translational Medicine
- Critical size limit of biodegradable nanoparticles for enhanced lymph node trafficking and paracortex penetration
- (2019) Gregory P. Howard et al. Nano Research
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
- (2019) Kimberly J. Hassett et al. Molecular Therapy-Nucleic Acids
- Material design for lymph node drug delivery
- (2019) Alex Schudel et al. Nature Reviews Materials
- Size-dependent cellular uptake and localization profiles of silver nanoparticles
- (2019) Meiyu Wu et al. International Journal of Nanomedicine
- Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia
- (2019) Ding An et al. EBioMedicine
- A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection
- (2019) Nurgun Kose et al. Science Immunology
- The droplet size of emulsion adjuvants has significant impact on their potency, due to differences in immune cell-recruitment and -activation
- (2019) Ruchi R. Shah et al. Scientific Reports
- A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates
- (2018) Staci Sabnis et al. MOLECULAR THERAPY
- Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity
- (2018) Shinu John et al. VACCINE
- Size-Controlled Lipid Nanoparticle Production Using Turbulent Mixing to Enhance Oral DNA Delivery
- (2018) Zhiyu He et al. Acta Biomaterialia
- Emerging Challenges and Opportunities in Infectious Disease Epidemiology
- (2018) Joseph A Lewnard et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
- (2017) Frank Liang et al. MOLECULAR THERAPY
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Modulating the immune system through nanotechnology
- (2017) Tamara G. Dacoba et al. SEMINARS IN IMMUNOLOGY
- Tools for translation: non-viral materials for therapeutic mRNA delivery
- (2017) Khalid A. Hajj et al. Nature Reviews Materials
- Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
- (2016) Sam Chen et al. JOURNAL OF CONTROLLED RELEASE
- Roles of Sterol Derivatives in Regulating the Properties of Phospholipid Bilayer Systems
- (2016) Tham Thi Bui et al. LANGMUIR
- Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses
- (2016) Ans De Beuckelaer et al. MOLECULAR THERAPY
- Human Immunodeficiency Virus (HIV)
- (2016) TRANSFUSION MEDICINE AND HEMOTHERAPY
- Sizing the optimal dimensions of a vaccine delivery system: a particulate matter
- (2015) Bram Slütter et al. Expert Opinion on Drug Delivery
- Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs
- (2015) Kevin J. Kauffman et al. NANO LETTERS
- A strategy for synthesis of lipid nanoparticles using microfluidic devices with a mixer structure
- (2015) Masatoshi Maeki et al. RSC Advances
- Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration
- (2014) Sam Chen et al. JOURNAL OF CONTROLLED RELEASE
- Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread
- (2014) Brian McCloskey et al. LANCET INFECTIOUS DISEASES
- The impact of size on particulate vaccine adjuvants
- (2014) Ruchi R Shah et al. Nanomedicine
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo
- (2013) Kenichi Niikura et al. ACS Nano
- Phagocytosis Dynamics Depends on Target Shape
- (2013) Debjani Paul et al. BIOPHYSICAL JOURNAL
- Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles
- (2013) Xinran Li et al. JOURNAL OF CONTROLLED RELEASE
- Priorities for CMV vaccine development
- (2013) Philip R. Krause et al. VACCINE
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
- (2012) Muthusamy Jayaraman et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Re-considering how particle size and other properties of antigen–adjuvant complexes impact on the immune responses
- (2012) Shiyu Yan et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
- (2012) Charlotte Pollard et al. MOLECULAR THERAPY
- Developing mRNA-vaccine technologies
- (2012) Thomas Schlake et al. RNA Biology
- Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens
- (2012) Douglas S. Watson et al. VACCINE
- Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
- (2012) Nathan M Belliveau et al. Molecular Therapy-Nucleic Acids
- Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines
- (2011) Myrra G. Carstens et al. VACCINE
- Endocytosis of nanomedicines
- (2010) Gaurav Sahay et al. JOURNAL OF CONTROLLED RELEASE
- Nanocarriers’ entry into the cell: relevance to drug delivery
- (2009) Hervé Hillaireau et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Vesicular Stomatitis Virus Enters Cells through Vesicles Incompletely Coated with Clathrin That Depend upon Actin for Internalization
- (2009) David K. Cureton et al. PLoS Pathogens
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Global trends in emerging infectious diseases
- (2008) Kate E. Jones et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search